Discovery of nontriterpenoids from the rot roots of Panax notoginseng with cytotoxicity and their molecular docking study and experimental validation. Issue 16 (6th April 2023)
- Record Type:
- Journal Article
- Title:
- Discovery of nontriterpenoids from the rot roots of Panax notoginseng with cytotoxicity and their molecular docking study and experimental validation. Issue 16 (6th April 2023)
- Main Title:
- Discovery of nontriterpenoids from the rot roots of Panax notoginseng with cytotoxicity and their molecular docking study and experimental validation
- Authors:
- Shang, Jia-Huan
Qiao, Yi-Jun
Zhu, Hong-Tao
Wang, Dong
Yang, Chong-Ren
Zhang, Ying-Jun - Abstract:
- Abstract : Nine new nontriterpenoids were identified from Panax notoginseng rot roots, and their cytotoxicities may be related to the EGFR inhibition. Abstract : Panax notoginseng ( PN ) is a well-known traditional Chinese medicine, with dammarane-type triterpenoid saponins characterized as major component and active ingredients, together with amino acids, flavonoids, polysaccharides, and polyacetylenes. The roots of PN are susceptible to root rot disease, which causes a huge loss and changes in the chemical components of this precious resource. In this study, sub-fractions of rot PN root extracts were preliminarily found to have admirable cytotoxicity on two human cancer cells. Further bioassay-guided isolation discovered nine new non-triterpenoids, including two novel N -methylacetamido-1-oxotetrahydropyrimidine alkaloids (1, 2 ), five 2 H -furanones or 2 H -pyranones (3–7 ), and two polyacetylenic alcohols (8, 9 ). Their structures were illuminated by extensive spectroscopic data, calculated ECD, and X-ray diffraction analysis. Among them, 3–7 were considered to be transformed from panaxatriol through the intermediates (8, 9 ). The new alkaloids (1, 2 ) displayed noteworthy cytotoxicity against five human cancer cells with IC50 values ranging from 14 to 24 μM. In silico target prediction and molecular docking studies showed that 1 and 2 may interact with EGFR, and were verified by the experimental inhibitory effect on EGFR tyrosine kinase.
- Is Part Of:
- RSC advances. Volume 13:Issue 16(2023)
- Journal:
- RSC advances
- Issue:
- Volume 13:Issue 16(2023)
- Issue Display:
- Volume 13, Issue 16 (2023)
- Year:
- 2023
- Volume:
- 13
- Issue:
- 16
- Issue Sort Value:
- 2023-0013-0016-0000
- Page Start:
- 11037
- Page End:
- 11043
- Publication Date:
- 2023-04-06
- Subjects:
- Chemistry -- Periodicals
540.5 - Journal URLs:
- http://pubs.rsc.org/en/Journals/JournalIssues/RA ↗
http://www.rsc.org/ ↗ - DOI:
- 10.1039/d3ra00720k ↗
- Languages:
- English
- ISSNs:
- 2046-2069
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8036.750300
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26913.xml